Sutro Biopharma (STRO) EBITDA Margin Growth (5y) (2022 - 2025)
Sutro Biopharma (STRO) EBITDA Margin Growth (5y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -27,639.00 |
| Sep 30, 2025 | -44,037.00 |
| Jun 30, 2025 | 16,813.00 |
| Mar 31, 2025 | -12,560.00 |
| Dec 31, 2024 | -30,991.00 |
| Sep 30, 2024 | -69,344.00 |
| Jun 30, 2024 | -5,937.00 |
| Mar 31, 2024 | -26,972.00 |
| Dec 31, 2023 | 5,510.00 |
| Sep 30, 2023 | -13,045.00 |
| Jun 30, 2023 | -23,160.00 |
| Mar 31, 2023 | -13,124.00 |
| Dec 31, 2022 | -19,478.00 |
| Sep 30, 2022 | -7,826.00 |